Observational Study; Clinical Effectiveness and Impact on Patient Reported Outcomes in Venezuelan Patients With Psoriasis After 16 Weeks of ADA Therapy
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 01 Dec 2016
At a glance
- Drugs Adalimumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors AbbVie
- 26 Nov 2016 Planned End Date changed from 1 May 2016 to 1 Mar 2016.
- 26 Nov 2016 Planned primary completion date changed from 1 May 2016 to 1 Mar 2016.
- 26 Nov 2016 Status changed from discontinued to withdrawn prior to enrolment.